Meteran, H.; Knudsen, A.Ø.; Jørgensen, T.L.; Nielsen, D.; Herrstedt, J.
Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer. J. Clin. Med. 2024, 13, 897.
https://doi.org/10.3390/jcm13030897
AMA Style
Meteran H, Knudsen AØ, Jørgensen TL, Nielsen D, Herrstedt J.
Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer. Journal of Clinical Medicine. 2024; 13(3):897.
https://doi.org/10.3390/jcm13030897
Chicago/Turabian Style
Meteran, Hanieh, Anja Ør Knudsen, Trine Lembrecht Jørgensen, Dorte Nielsen, and Jørn Herrstedt.
2024. "Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer" Journal of Clinical Medicine 13, no. 3: 897.
https://doi.org/10.3390/jcm13030897
APA Style
Meteran, H., Knudsen, A. Ø., Jørgensen, T. L., Nielsen, D., & Herrstedt, J.
(2024). Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer. Journal of Clinical Medicine, 13(3), 897.
https://doi.org/10.3390/jcm13030897
